Chernousov A D, Fontalin L N, Kondrat'eva T K
Biull Eksp Biol Med. 1979 May;87(5):449-52.
The ability to the development of delayed hypersensitivity (DHS) to the appropriate antigen was studied in mice treated with large doses of SRBC and cyclophosphamide at varying time prior to the experiment. Suppression of DHS development induced by administering either the cytostatic alone or a large dose of the antigen was examined at the same periods of time. The combined treatment was shown to induce tolerance according to diverse tests for DHS (skin and macrophage migration inhibition tests). At the basis of this tolerance lies genuine deficiency of the appropriate clone of T cells. Administration of cyclophosphamide alone leads to a slight suppression of DHS, while a large dose of the antigen induces a different form of areactivity due to the suppressor cells whose nature is not yet clear.
在实验前不同时间用大剂量绵羊红细胞(SRBC)和环磷酰胺处理的小鼠中,研究了对相应抗原产生迟发型超敏反应(DHS)的能力。在相同时间段内,检测单独给予细胞抑制剂或大剂量抗原所诱导的DHS发育抑制情况。根据多种DHS检测方法(皮肤和巨噬细胞迁移抑制试验),联合治疗显示可诱导耐受性。这种耐受性的基础是T细胞相应克隆的真正缺陷。单独给予环磷酰胺会导致DHS略有抑制,而大剂量抗原由于性质尚不清楚的抑制细胞会诱导出不同形式的无反应性。